
Marcus (MCS) Stock Forecast & Price Target
Marcus (MCS) Analyst Ratings
Bulls say
Marcus Corp's positive outlook is supported by a projected EBITDA improvement to $112.3 million and a revenue growth of 2.5% reaching $791 million by 2026, indicating recovery and expansion in both its movie theatre and hotels segments. Notably, the company experienced a 7% year-over-year increase in attendance, with concession revenue rising nearly 14%, reflecting successful film releases that resonate well within its Midwestern markets. Additionally, both segments are expected to continue growing, with the Hotels segment showing normalized growth of approximately 3% to 4% for Q3 2025, further reinforcing the financial strength and operational resilience of Marcus Corp.
Bears say
Marcus Corp has experienced a 16.6% decline in admissions revenues, which underperforms the estimated industry box office decrease of 12%, indicating significant weakness in its performance relative to peers. This revenue drop, along with a total EBITDA of $40.4 million that is substantially lower year-over-year, suggests a challenging environment for the company’s core movie theatre business. Additionally, with expectations for flat hotel profitability through FY26 and a potential macroeconomic slowdown, the outlook appears increasingly cautious, further contributing to a negative sentiment surrounding Marcus's stock.
This aggregate rating is based on analysts' research of Marcus and is not a guaranteed prediction by Public.com or investment advice.
Marcus (MCS) Analyst Forecast & Price Prediction
Start investing in Marcus (MCS)
Order type
Buy in
Order amount
Est. shares
0 shares